CTLA4 and cancer: Immune checkpoint inhibitors, such as the antibody against PD-1, CTLA-4, TIM-3, or LAG-3 protein, can block the checkpoint proteins from binding with their partner proteins, which can prevent the “off” signal from being sent and allow T cells to kill cancer cells by alleviating the inhibitory effect (Figure 4) [42].